Cargando…

HIV-Infected Subjects With Poor CD4 T-Cell Recovery Despite Effective Therapy Express High Levels of OX40 and α4β7 on CD4 T-Cells Prior Therapy Initiation

BACKGROUND: HIV-infected subjects with suboptimal CD4 restoration despite suppressive combined antiretroviral treatment (cART) (immunodiscordant subjects) have been classically characterized after a variable period of time under cART. Recently, we have reported that an increased frequency of prolife...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosado-Sánchez, Isaac, Herrero-Fernández, Inés, Genebat, Miguel, Del Romero, Jorge, Riera, Melchor, Podzamczer, Daniel, Olalla, Julián, Vidal, Francesc, Muñoz-Fernández, Mª Angeles, Leal, Manuel, Pacheco, Yolanda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058017/ https://www.ncbi.nlm.nih.gov/pubmed/30073002 http://dx.doi.org/10.3389/fimmu.2018.01673

Ejemplares similares

Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination
por: Herrero-Fernández, Inés, et al.
Publicado: (2018)

Immunological features beyond CD4/CD8 ratio values in older individuals
por: Garrido-Rodríguez, Vanesa, et al.
Publicado: (2021)

Partial restoration of gut‐mucosal dysbiosis in late‐treated HIV‐infected subjects with CD4 T‐cell recovery
por: Olivas‐Martínez, Israel, et al.
Publicado: (2022)

New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144
por: Hernández-Walias, Francisco, et al.
Publicado: (2020)

Multimeric forms of CD40 ligand (CD40L), 4-1BB ligand (4-1BBL), OX40 ligand (OX40L), CD27L/CD70, and other TNFSFs as tools for adoptive cell therapy
por: Kornbluth, Richard S
Publicado: (2013)

135 HIV-associated immunodeficiency despite potent antiretroviral therapy with CD4 T cell reconstitution
por: Poonia, Bhawna, et al.
Publicado: (2014)

The MRC OX-22- CD4+ T cells that help B cells in secondary immune responses derive from naive precursors with the MRC OX-22+ CD4+ phenotype
Publicado: (1989)

Anti-CD19 CAR T-cell therapy remission despite prior anti-CD19 antibody Tafasitamab in relapsed/refractory DLBCL
por: Tabbara, Nadeem, et al.
Publicado: (2021)

Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy
por: Yeregui, Elena, et al.
Publicado: (2022)

OX40 signaling is involved in the autoactivation of CD4(+)CD28(−) T cells and contributes to the pathogenesis of autoimmune arthritis
por: Jiang, Juean, et al.
Publicado: (2017)

CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4 + T lymphocytes
por: Jiménez-Fernández, María, et al.
Publicado: (2022)

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
por: Martínez-Sanz, Javier, et al.
Publicado: (2023)

Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004–2018
por: Domínguez-Domínguez, Lourdes, et al.
Publicado: (2022)

A mathematical model of combined CD8 T cell costimulation by 4-1BB (CD137) and OX40 (CD134) receptors
por: Konstorum, Anna, et al.
Publicado: (2019)

Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers
por: Vitallé, Joana, et al.
Publicado: (2018)

A baseline metabolomic signature is associated with immunological CD4(+) T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients
por: Rodríguez-Gallego, Esther, et al.
Publicado: (2018)

CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease
por: Gomez-Bris, Raquel, et al.
Publicado: (2023)

DBP rs7041 and DHCR7 rs3829251 are Linked to CD4(+) Recovery in HIV Patients on Antiretroviral Therapy
por: Resino, Salvador, et al.
Publicado: (2022)

Obstacles to Anti-CD4 Therapy in Rheumatoid Arthritis
por: Kalden, Joachim R, et al.
Publicado: (2000)

CD4 cell response to interval therapy with natalizumab
por: Berkovich, Regina, et al.
Publicado: (2015)

Long-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy
por: Luz, Paula M., et al.
Publicado: (2014)

Early and Partial Reduction in CD4(+)Foxp3(+) Regulatory T Cells during Colitis-Associated Colon Cancer Induces CD4(+) and CD8(+) T Cell Activation Inhibiting Tumorigenesis
por: Olguín, Jonadab E., et al.
Publicado: (2018)

Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury
por: Suzuki, Kazuo, et al.
Publicado: (2022)

CD4 T Cell Cytokine Differentiation: The B Cell Activation Molecule, OX40 Ligand, Instructs CD4 T Cells to Express Interleukin 4 and Upregulates Expression of the Chemokine Receptor, Blr-1
por: Flynn, Sarah, et al.
Publicado: (1998)

Therapy with CD4(+)CD25(+) T regulatory cells – should we be afraid of cancer?
por: Gliwiński, Mateusz, et al.
Publicado: (2019)

Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity
por: Nawaf, Maher G., et al.
Publicado: (2017)

Combining CD4 recovery and CD4: CD8 ratio restoration as an indicator for evaluating the outcome of continued antiretroviral therapy: an observational cohort study
por: Lee, Shui Shan, et al.
Publicado: (2017)

Critical role of OX40 in the expansion and survival of CD4 T-cell-derived double-negative T cells
por: Sun, Guangyong, et al.
Publicado: (2018)

CD4+ Primary T Cells Expressing HCV-Core Protein Upregulate Foxp3 and IL-10, Suppressing CD4 and CD8 T Cells
por: Fernandez-Ponce, Cecilia, et al.
Publicado: (2014)

Immune activation despite preserved CD4 T cells in perinatally HIV-infected children and adolescents
por: Alvarez, Patricia, et al.
Publicado: (2017)

Distinctive CD26 Expression on CD4 T-Cell Subsets
por: Cordero, Oscar J., et al.
Publicado: (2021)

Human CD4(+)CD25(+)CD226(-) Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4(+)CD25(+)CD127(lo/-) Tregs for Adoptive Cell Therapy
por: Brown, Matthew E., et al.
Publicado: (2022)

Computational modeling of heterogeneity and function of CD4+ T cells
por: Carbo, Adria, et al.
Publicado: (2014)

Antiangiogenic Therapy Impedes Infiltration by CD4+ and CD8+ Cells Into an Early Colon Tumor
por: Yang, Yoon Jung, et al.
Publicado: (2015)

Regulation of CD4(+)CD8(−)CD25(+) and CD4(+)CD8(+)CD25(+) T cells by gut microbiota in chicken
por: Lee, In Kyu, et al.
Publicado: (2018)

HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality
por: Serrano-Villar, Sergio, et al.
Publicado: (2014)

IL7RA rs6897932 Polymorphism Is Associated with Better CD4(+) T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy
por: Resino, Salvador, et al.
Publicado: (2019)

Functional Tolerance is Maintained Despite Proliferation of CD4 T Cells after Encounter with Tissue-derived Antigen
por: Ausubel, Lara J., et al.
Publicado: (2002)

Narrowing the Gap: Preserving Repertoire Diversity Despite Clonal Selection during the CD4 T Cell Response
por: Merkenschlager, Julia, et al.
Publicado: (2015)

Stable HIV Reservoir Despite Prolonged Low-Dose Mycophenolate to Limit CD4+ T-cell Proliferation
por: Schiffer, Joshua T, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_afi9l8j10mlso7b8a6nhar16m3